期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Gut microbiome and metabolic-associated fatty liver disease:Current status and potential applications
1
作者 Gong-Jing Guo Fei Yao +1 位作者 Wei-Peng Lu hao-ming xu 《World Journal of Hepatology》 2023年第7期867-882,共16页
Metabolic-associated fatty liver disease(MAFLD)is one of the most common chronic liver diseases worldwide.In recent years,the occurrence rate of MAFLD has been on the rise,mainly due to lifestyle changes,high-calorie ... Metabolic-associated fatty liver disease(MAFLD)is one of the most common chronic liver diseases worldwide.In recent years,the occurrence rate of MAFLD has been on the rise,mainly due to lifestyle changes,high-calorie diets,and imbalanced dietary structures,thereby posing a threat to human health and creating heavy social and economic burdens.With the development of 16S sequencing and integrated multi-omics analysis,the role of the gut microbiota(GM)and its metabolites in MAFLD has been further recognized.The GM plays a role in digestion,energy metabolism,vitamin synthesis,the prevention of pathogenic bacteria colonisation,and immunoregulation.The gut-liver axis is one of the vital links between the GM and the liver.Toxic substances in the intestine can enter the liver through the portal vascular system when the intestinal barrier is severely damaged.The liver also influences the GM in various ways,such as bile acid circulation.The gut-liver axis is essential in maintaining the body’s normal physiological state and plays a role in the onset and prognosis of many diseases,including MAFLD.This article reviews the status of the GM and MAFLD and summarizes the GM characteristics in MAFLD.The relationship between the GM and MAFLD is discussed in terms of bile acid circulation,energy metabolism,micronutrients,and signalling pathways.Current MAFLD treat ments targeting the GM are also listed. 展开更多
关键词 Metabolic-associated fatty liver disease Gut microbiota Current status APPLICATION
下载PDF
Formation of explosively formed penetrator with fins and its flight characteristics 被引量:7
2
作者 Jian-qing LIU Wen-bin GU +2 位作者 Ming LU hao-ming xu Shuang-zhang WU 《Defence Technology(防务技术)》 SCIE EI CAS 2014年第2期119-123,共5页
The ultimate goal of weapon system employing an explosively formed penetrator(EFP) is to defeat a target at the longest standoff.In order to do this,an EFP must be aerodynamically stable so as to strike the target at ... The ultimate goal of weapon system employing an explosively formed penetrator(EFP) is to defeat a target at the longest standoff.In order to do this,an EFP must be aerodynamically stable so as to strike the target at a small angle of obliquity,and the decay velocity per meter of EFP must be smaller at extended standoff.As the angle of attack increases,the penetration ability of EFP greatly reduces.The fins improve the EFP aeroballistic characteristics and decrease the flight drag of EFP as well.EFP with fins formed by three-point initiation is presented.The formation of EFP with fins is studied by LS-DYNA,and the aeroballistics is studied through experiment.The experimental results show that the decay velocity per meter of EFP with fins is much smaller than that of normal EFP.and the attitude angle steadily decreases. 展开更多
关键词 爆炸成型弹丸 飞行特性 散热片 LS-DYNA EFP 衰减速度 武器系统 动力稳定
下载PDF
Therapeutic advances in non-alcoholic fatty liver disease:A microbiota-centered view 被引量:5
3
作者 Hui-Ting Chen Hong-Li Huang +2 位作者 Yong-Qiang Li hao-ming xu Yong-Jian Zhou 《World Journal of Gastroenterology》 SCIE CAS 2020年第16期1901-1911,共11页
Non-alcoholic fatty liver disease(NAFLD)is a highly prevalent metabolic disorder with steadily increasing incidence rates worldwide,especially in the West.There are no drugs available at present to treat NAFLD,and the... Non-alcoholic fatty liver disease(NAFLD)is a highly prevalent metabolic disorder with steadily increasing incidence rates worldwide,especially in the West.There are no drugs available at present to treat NAFLD,and the primary therapeutic options include weight loss and the combination of healthy diet and exercise.Therefore,novel interventions are required that can target the underlying risk factors.Gut microbiota is an“invisible organ”of the human body and vital for normal metabolism and immuno-modulation.The number and diversity of microbes differ across the gastrointestinal tract from the mouth to the anus,and is most abundant in the intestine.Since dysregulated gut microbiota is an underlying pathological factor of NAFLD,it is a viable therapeutic target that can be modulated by antibiotics,probiotics,prebiotics,synbiotics,fecal microbiota transplantation,and microbial metabolites.In this review,we summarize the most recent advances in gut microbiota-targeted therapies against NAFLD in clinical and experimental studies,and critically evaluate novel targets and strategies for treating NAFLD. 展开更多
关键词 Non-alcoholic fatty liver disease Gut MICROBIOTA Probiotics PREBIOTICS FECAL MICROBIOTA transplantation Metabolites
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部